Weight Loss Drug Ads: Good or Bad?

Another favourite from our archives...Almost every movie and television show needs cars, and auto companies are happy to supply them – because it helps sell a lot of cars.We’ll look back at James Bond and Starsky & Hutch, and explore auto partnerships with movie franchises like T ...  Show more

From the Under The Influence Archives, one of our favourites....Take a walk down any busy main street, and you’ll probably see one of the oldest forms of advertising: The sandwich board. They have been around for over 200 years. Cities try and ban them.Storekeepers love them. The ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big- ...  Show more

Yes, drugs like Ozempic, Wegovy, and Mounjaro can help people lose weight, but at what cost? Dr. Sanjay Gupta explores why these drugs may not be the right fit for everyone. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices